Segment disclosures

Company overview

Gossamer Bio, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 19 retained observations 13 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Reporting Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=goss:ReportingSegmentMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3038431000 USD20261110Open filing evidence
2026-01-01 – 2026-09-3064624000 USD20261110Open filing evidence
2026-04-01 – 2026-06-309238000 USD20260813Open filing evidence
2026-01-01 – 2026-06-3026193000 USD20260813Open filing evidence
2026-01-01 – 2026-03-3116955000 USD20260515Open filing evidence
2025-01-01 – 2025-12-3148471000 USD20260317Open filing evidence
2025-07-01 – 2025-09-3013294000 USD20261110Open filing evidence
2025-01-01 – 2025-09-3034672000 USD20261110Open filing evidence
2025-04-01 – 2025-06-3011489000 USD20260813Open filing evidence
2025-01-01 – 2025-06-3021378000 USD20260813Open filing evidence
2025-01-01 – 2025-03-319889000 USD20260515Open filing evidence
2024-01-01 – 2024-12-31114701000 USD20260317Open filing evidence
2024-07-01 – 2024-09-309480000 USD20251105Open filing evidence
2024-01-01 – 2024-09-30105322000 USD20251105Open filing evidence
2024-04-01 – 2024-06-3095842000 USD20250805Open filing evidence
2024-01-01 – 2024-06-3095842000 USD20250805Open filing evidence
2024-01-01 – 2024-03-310 USD20250515Open filing evidence
2023-01-01 – 2023-12-310 USD20260317Open filing evidence
2022-01-01 – 2022-12-310 USD20250313Open filing evidence